Bayer begins Phase I study targeting GPC3 with alpha radiopharmaceutical in advanced hepatocellular carcinoma patients Ruchika Sharma4 May 2025 12:30 PM ISTBerlin: Bayer has announced the initiation of a Phase I clinical trial with 225Ac-GPC3 (BAY 3547926), an investigational targeted alpha...
Bristol Myers Squibb gets European Commission nod for Opdivo plus Yervoy for Hepatocellular Carcinoma Ruchika Sharma9 March 2025 12:30 PM ISTPrinceton: Bristol Myers Squibb has announced that the European Commission (EC) has approved Opdivo (nivolumab) plus Yervoy (ipilimumab) for the...
Hepatocellular Carcinoma After Hepatitis C Cure: Study Emphasizes The Need for Long-Term Surveillance Medha Baranwal7 Feb 2025 9:45 PM ISTChina: A recent study published in the Annals of Hepatology has emphasized the influence of age on hepatocellular carcinoma (HCC) development...
Medical Bulletin 04/ October/ 2024 Dr. Bhumika Maikhuri4 Oct 2024 3:00 PM ISTHere are the top medical news for the day:Higher Prevalence of Mental Disorder and Suicidality Among Transgender When Compared to Cisgender...
Obesity and Diabetes May Be Risk Factors for Recurrence of Hepatocellular Carcinoma, Study Reveals Dr. Bhumika Maikhuri4 Oct 2024 8:00 AM ISTA recent study has highlighted that the coexistence of obesity and Diabetes mellitus increased late recurrence and worsened prognosis in patients with...
Diabetes and obesity tied to Increased risk of liver cancer relapse after resection: Study Dr. Kamal Kant Kohli4 Oct 2024 2:00 AM ISTHepatocellular carcinoma, a type of liver cancer associated with hepatitis infections, is known to have a high recurrence rate after cancer removal....
Age no bar for Elderly Patients undergoing Liver Resection for Hepatocellular Carcinoma, Study Finds Medha Baranwal20 Sept 2024 8:00 PM ISTAge should not automatically preclude elderly patients from undergoing liver resection for hepatocellular carcinoma.Egypt: Curative liver resection...
USFDA accepts application for Opdivo plus Yervoy for unresectable hepatocellular carcinoma Ruchika Sharma22 Aug 2024 4:30 PM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental Biologics License...
Bristol Myers Squibb gets EMA validation of application for Opdivo plus Yervoy for Hepatocellular Carcinoma Ruchika Sharma21 July 2024 3:30 PM ISTPrinceton: Bristol Myers Squibb has announced that the European Medicines Agency (EMA) has validated its Type II variation application for...
Ultrasonography of hepatocellular carcinoma: From diagnosis to prognosis Dr. Kamal Kant Kohli19 July 2024 3:15 AM ISTHepatocellular carcinoma (HCC) is a primary malignancy of the liver and one of the leading causes of cancer-related deaths worldwide. Early detection...
Liver Resection Improves Survival in Patients with Early Multinodular HCC Jacinthlyn Sylvia17 May 2024 6:00 AM ISTA recent study published has cast doubt on the 2022 Barcelona Clinic Liver Cancer (BCLC) algorithm that currently advises against liver resection (LR)...
Medical Bulletin 27/ April/ 2024 Roshni Dhar27 April 2024 3:00 PM ISTHere are the top medical news for the day:Can cancer vaccine with immunotherapy shrink liver tumor?According to a study published in the journal...
